Human TFPI ELISA Kit

Sensitivity

7.2 pg/mL

Range

15.6-1000 pg/mL , 62.5-2000 pg/mL

Reactivity

Human

Cat no : KE00202

Synonyms

EPI, Extrinsic pathway inhibitor, LACI, TFI, TFPI, TFPI1



Product Information

KE00202 is a solid phase sandwich Enzyme Linked-Immuno-Sorbent Assay (Sandwich ELISA). The TFPI ELISA kit is to be used to detect and quantify protein levels of endogenous TFPI. The assay recognizes human TFPI. An antibody specific for TFPI has been pre-coated onto the microwells. The TFPI protein in samples is captured by the coated antibody after incubation.Following extensive washing, another antibody of biotinylated specific for TFPI is added to detect the captured TFPI protein. For signal development, Sterptravidin-HRP is added, followed by Tetramethyl-benzidine (TMB) reagent. Solution containing sulfuric acid is used to stop color development and the color intensity which is proportional to the quantity of bound protein is measurable at 450 nm with the correction wavelength set at 630 nm.

Product name Human TFPI ELISA Kit
Tests 1 X 96 well plate
Sample type Serum, Plasma, Cell culture supernatants
Assay type Sandwich
Sensitivity 7.2 pg/mL
Range 15.6-1000 pg/mL , 62.5-2000 pg/mL
Reactivity Human
Tested applications Sandwich ELISA
Gene ID (NCBI) 7035

Recovery

Sample TypeAverageRange
Human plasma75%-122%107%
Cell culture supernatants72%-120%89%

IntraAssay

Samplenmean ( pg/mL)SDCV%
12023.32.29.4
22075.75.47.1
320312.915.65.0

InterAssay

Samplenmean ( pg/mL)SDCV%
12422.91.56.6
22466.85.68.5
324314.218.15.8

Background Information

Tissue factor pathway inhibitor (TFPI) is a critical anticoagulant protein present in endothelium and platelets. TFPI is produced as two major isoforms in humans, TFPIa and TFPIb that result from alternative splicing. The TFPIb isoform localizes to the endothelium surface where it is a potent inhibitor of tissue factor-factor VIIa complexes that initiate blood coagulation. The TFPIa isoform is present in platelets. TFPI is a Kunitz-type serine protease inhibitor that exerts anticoagulant activity by blocking early procoagulant stimulia. TFPI can enhance anti-thrombotic treatment in sepsis, inflammatory diseases, and cardiovascular diseases. In plasma, 80% of TFPI is carboxy-terminal truncated and circulates bound primarily to low-density lipoproteins (LDL), with the levels of the latter having an impact on plasma TFPI levels. The other 20% is unbound free-form TFPI characterised by the K3 domain.

Properties

Storage Instructions All the reagents are stored at 2-8℃ for 6 months or -20℃ for 12 months. Refer to the protocol for further storage instructions.
Synonyms EPI, Extrinsic pathway inhibitor, LACI, TFI, TFPI, TFPI1